Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases

NCT07346170 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07346170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07346170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
November 30, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spine metastasis, stereotactic body radiation therapy (sbrt)